A Phase I Open-Label, Dose-Escalating, Multi-Center Trial to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients with Neovascular Age-Related Macular Degeneration (AMD)
Clinical Trial Grant
Administered By
Ophthalmology
Awarded By
PanOptica
Start Date
March 25, 2014
End Date
April 1, 2019
Administered By
Ophthalmology
Awarded By
PanOptica
Start Date
March 25, 2014
End Date
April 1, 2019